Studies in the Area of Anaplastic Large Cell Lymphoma Reported from Department of Hematology and Hematopoietic Cell Transplantation (Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone Followed By Brentuximab ...)

Press/Media

PeriodSep 25 2024

Media coverage

1

Media coverage

  • TitleStudies in the Area of Anaplastic Large Cell Lymphoma Reported from Department of Hematology and Hematopoietic Cell Transplantation (Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone Followed By Brentuximab ...)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date09/25/24
    PersonsLu Chen